BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 38637783)

  • 1. Knowledge-based dose prediction models to inform gynecologic brachytherapy needle supplementation for locally advanced cervical cancer.
    Kallis K; Mayadev J; Kisling K; Brown D; Scanderbeg D; Ray X; Cortes K; Simon A; Yashar CM; Einck JP; Mell LK; Moore KL; Meyers SM
    Brachytherapy; 2021; 20(6):1187-1199. PubMed ID: 34393059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neural network dose prediction for cervical brachytherapy: Overcoming data scarcity for applicator-specific models.
    Moore LC; Ahern F; Li L; Kallis K; Kisling K; Cortes KG; Nwachukwu C; Rash D; Yashar CM; Mayadev J; Zou J; Vasconcelos N; Meyers SM
    Med Phys; 2024 May; ():. PubMed ID: 38814165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hands-on-training tailored in response to pre-questionnaire-based survey on image-guided brachytherapy effectively reduces anxiety about its implementation.
    Okonogi N; Murakami N; Takatsu J; Iijima K; Kawamoto T; Oshima M; Okuma K; Masui K; Murata K; Okamoto H; Yoshida K; Noda SE; Numajiri H; Watanabe M; Tsuchida K; Muramoto Y; Karino T; Ohno T; Shikama N
    J Radiat Res; 2024 May; 65(3):323-327. PubMed ID: 38544297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Color VISION for improved ultrasound visualization of brachytherapy needles.
    Dupere JM; Brost EE; Hainy ME; Lee CU; Urban MW; Stish BJ; Deufel CL
    Med Phys; 2024 Jun; 51(6):4340-4350. PubMed ID: 38629912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a novel scoring system to predict the risk of uterine perforation during intracavitary brachytherapy for cervical cancer.
    M Parvath ES; John NO; Sathyamurthy A; Ramireddy JK; Ram TS
    J Gynecol Oncol; 2024 May; 35(3):e35. PubMed ID: 38178701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are prophylactic antibiotics required for combined intracavitary and interstitial brachytherapy of gynecologic cancers?
    Kumazawa T; Ohkubo Y; Mochida K; Kondo S; Oguchi O; Yoshida D
    J Radiat Res; 2024 May; 65(3):387-392. PubMed ID: 38610064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A practical guide to hybrid interstitial/intracavitary brachytherapy for locally-advanced cervical cancer.
    Ladbury C; Harkenrider M; Taunk N; Fisher C; Mayadev J; Venkat P; Yashar C; Gaffney D; Beriwal S; Glaser S
    Brachytherapy; 2023; 22(5):640-648. PubMed ID: 37481370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-dimensional-guided perineal-based interstitial brachytherapy in cervical cancer: A systematic review of technique, local control and toxicities.
    Mendez LC; Weiss Y; D'Souza D; Ravi A; Barbera L; Leung E
    Radiother Oncol; 2017 May; 123(2):312-318. PubMed ID: 28351521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interstitial round needles should not be used for cervical cancer patient treated with intracavitary/ interstitial brachytherapy using a Venezia applicator : a case report.
    Takagawa Y; Izumi S; Takahashi E; Kita M
    BMC Womens Health; 2024 Apr; 24(1):249. PubMed ID: 38637783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined intracavitary and interstitial brachytherapy of cervical cancer using the novel hybrid applicator Venezia: Clinical feasibility and initial results.
    Walter F; Maihöfer C; Schüttrumpf L; Well J; Burges A; Ertl-Wagner B; Mahner S; Belka C; Gallwas J; Corradini S
    Brachytherapy; 2018; 17(5):775-781. PubMed ID: 29941345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcome of combined intracavitary / interstitial brachytherapy using a hybrid applicator in locally advanced cervical cancer.
    Rogowski P; Rottler M; Walter F; Saicic S; Niyazi M; Well J; Nierer L; Trillsch F; Burges A; Mahner S; Belka C; Corradini S
    Gynecol Oncol; 2022 Sep; 166(3):576-581. PubMed ID: 35764443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel intra pre-plan method of interstitial needle optimization for cervical cancer patients treated with Venezia applicator brachytherapy: a technical note.
    Takagawa Y; Tsuchiya K; Izumi S; Okano T; Takahashi E; Wakamatsu Y; Kamoshida K; Miyake Y; Kita M
    J Contemp Brachytherapy; 2022 Jun; 14(3):260-267. PubMed ID: 36199991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proof of principle: Applicator-guided stereotactic IMRT boost in combination with 3D MRI-based brachytherapy in locally advanced cervical cancer.
    Assenholt MS; Vestergaard A; Kallehauge JF; Mohamed S; Nielsen SK; Petersen JB; Fokdal L; Lindegaard JC; Tanderup K
    Brachytherapy; 2014; 13(4):361-8. PubMed ID: 24656732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical feasibility of combined intracavitary/interstitial brachytherapy in locally advanced cervical cancer employing MRI with a tandem/ring applicator in situ and virtual preplanning of the interstitial component.
    Fokdal L; Tanderup K; Hokland SB; Røhl L; Pedersen EM; Nielsen SK; Paludan M; Lindegaard JC
    Radiother Oncol; 2013 Apr; 107(1):63-8. PubMed ID: 23452917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy for the treatment of recurrent cervical cancer: an update of the literature.
    D'Oria O; Bogani G; Cuccu I; D'Auge TG; Di Donato V; Caserta D; Giannini A
    Expert Opin Pharmacother; 2024; 25(1):55-65. PubMed ID: 38159033
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.